AbbVie Jumps After Q4 Earnings Beat, Skyrizi And Rinvoq Boom Offsets Humira Decline
aol.com/abbvie-jumps-q4-earnings-beat-170059239.html
AbbVie Inc. (NYSE:ABBV) shares are trading higher on Friday. The company reported fourth-quarter adjusted earnings per share of $2.16, beating the street view of $2.11.
Quarterly sales of $15.102 billion, outpacing the analyst consensus estimate of $14.827 billion. Revenues soared 5.6%…
This story appeared on aol.com, 2025-01-31 18:09:12.679000.